This trial is completed!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
and you are
between 30 and 70
years old
The phase for this study is not defined.
Show me locations

The purpose

The purpose of this double blind, randomized and sham controlled study is to determine whether renal denervation in terms of catheter based ablation in the renal arteries is effective in lowering blood pressure in patients with treatment resistant hypertension. The blood pressure lowering effect will be evaluated by 24 hours ambulatory blood pressure measurement at baseline and after 1, 3 and 6 months of follow up. Secondary end point evaluation concerns hemodynamic measures using echocardiography, applanation tonometry and forearm plethysmography.

Provided treatments

  • Procedure: Renal artery ablation
  • Procedure: Renal angiography

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT01459900. The sponsor of the trial is Aarhus University Hospital Skejby and it is looking for 69 volunteers for the current phase.
Official trial title:
Renal Sympathectomy in Treatment Resistant Essential Hypertension, a Sham Controlled Randomized Trial